Furthermore, no evidence for any association between these variants in MMR genes and breast cancer has been seen in larger case control studies [1], segregation analysis [23], nor in prospective analysis of PV carriers [24], with the possible exception of MSH6 in BRIDGES, which was borderline significant at two-fold risk [16]. This evidence concerns the gene MSH6 and breast carcinoma.